365 WMG Private Fund I Primus Fund LLC Purchases New Holdings in Procter & Gamble Company (The) $PG

Key Points

• 365 WMG Private Fund I Primus Fund LLC initiated a Procter & Gamble position of 9,388 shares valued at approximately $1.36 million in the third quarter. Institutional investors collectively own 65.77% of PG.
• Procter & Gamble reported quarterly EPS of $1.43, exceeding estimates by $0.02, while revenue rose 1.5% year over year to $21.20 billion but fell short of expectations.
• The company declared a quarterly dividend of $1.0885 per share, representing an annualized payout of $4.35 and a 2.8% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $162.20, though limited organic growth and pricing pressures remain concerns.

365 WMG Private Fund I Primus Fund LLC purchased a new stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 9,388 shares of the company's stock, valued at approximately $1,364,000.

Other institutional investors have also recently made changes to their positions in the company. Baxter Bros Inc. bought a new position in Procter & Gamble during the 2nd quarter worth $12,381,000. Empowered Funds LLC acquired a new position in Procter & Gamble in the 2nd quarter valued at $53,549,000. Bank of America Corp DE bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at $3,850,628,000. Rokos Capital Management LLP bought a new stake in shares of Procter & Gamble during the 1st quarter valued at $29,914,000. Finally, State Street Corp lifted its position in shares of Procter & Gamble by 1.0% during the 2nd quarter. State Street Corp now owns 102,216,308 shares of the company's stock valued at $14,988,999,000 after acquiring an additional 965,461 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.

Procter & Gamble Price Performance

Procter & Gamble stock opened at $156.97 on Thursday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $167.25. The stock has a market capitalization of $364.58 billion, a P/E ratio of 23.12, a price-to-earnings-growth ratio of 3.96 and a beta of 0.39. The stock has a fifty day moving average of $147.65 and a 200-day moving average of $146.83.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. The business had revenue of $21.20 billion for the quarter, compared to analyst estimates of $21.38 billion. During the same period last year, the firm posted $1.48 earnings per share. Procter & Gamble's revenue was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, sell-side analysts expect that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be paid a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble's payout ratio is presently 65.71%.

Analyst Ratings Changes

A number of research analysts recently commented on PG shares. Bank of America decreased their price target on Procter & Gamble from $170.00 to $166.00 and set a "buy" rating on the stock in a research report on Friday, July 10th. TD Cowen reaffirmed a "hold" rating and issued a $150.00 price target on shares of Procter & Gamble in a research note on Wednesday, September 30th. JPMorgan Chase & Co. cut their price objective on shares of Procter & Gamble from $164.00 to $162.00 and set an "overweight" rating for the company in a research report on Thursday, July 16th. UBS Group reiterated a "buy" rating on shares of Procter & Gamble in a research note on Friday, October 16th. Finally, Jefferies Financial Group raised their target price on shares of Procter & Gamble from $177.00 to $179.00 and gave the company a "buy" rating in a report on Friday, June 26th. Fourteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $162.20.

Insider Activity

In other news, CFO Andre Schulten sold 3,914 shares of the company's stock in a transaction on Monday, October 5th. The shares were sold at an average price of $145.34, for a total transaction of $568,860.76. Following the completion of the transaction, the chief financial officer directly owned 65,618 shares in the company, valued at approximately $9,536,920.12. This represents a 5.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marc Pritchard sold 4,030 shares of the stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the transaction, the insider owned 187,001 shares of the company's stock, valued at $26,888,873.79. The trade was a 2.11% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 15,135 shares of company stock valued at $2,189,970. 0.23% of the stock is currently owned by insiders.

Procter & Gamble News Roundup

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Procter & Gamble’s dividend remains a key support for the stock. The company recently recorded its 70th consecutive annual dividend increase, reinforcing its appeal to income-focused investors, particularly while interest rates remain elevated. The Ultimate Dividend Growth Stock to Buy With $100 Right Now
• Positive Sentiment: Royal Bank of Canada reaffirmed its “outperform” rating and maintained a $166 price target, implying additional upside from the referenced trading level. Benzinga analyst-rating report
• Neutral Sentiment: Investors are comparing PG’s dependable profitability and cash flow from essential household products with higher-risk consumer brands such as Nike. This supports PG’s defensive profile but does not provide a new earnings catalyst. Nike vs. Procter & Gamble
• Negative Sentiment: Procter & Gamble expects only 1% to 3% organic sales growth, raising concerns that the company’s large brands may be struggling to generate stronger underlying demand. Procter & Gamble Expects 1% to 3% Organic Growth
• Negative Sentiment: The earnings preview identifies a central risk: recovering product volumes could be offset by pricing headwinds, potentially limiting revenue growth and margins. Procter & Gamble Earnings Preview
• Negative Sentiment: Options-market activity indicates traders are positioned for PG shares to decline following the earnings release, reflecting elevated near-term uncertainty. Barchart Earnings Analysis

Procter & Gamble Company Profile

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.